Build continuing professional development sustaining competence in pharmaceutical raw material control.
Quality Control of Pharmaceutical Raw Materials
Move pharmaceutical raw material control from general awareness to a repeatable, reviewable practice.
📍 Tunis🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
Variation in pharmaceutical raw material control between shifts and sites is where avoidable harm lives. The data supporting material control is usually present but rarely assembled into a decision. Applied research in health and pharmaceutical services consistently shows that early structure around this aspect of health and pharmaceutical services reduces downstream rework. The content is relevant to those who own pharmaceutical raw material control and to those who are held accountable for its results. Content is organised around the decisions practitioners actually face in this area of health and pharmaceutical services, not around theory headings. What blocks progress on material control is usually unclear ownership rather than unclear intent. Participants apply pharmaceutical raw material control to their own clinical service throughout, so the output is directly usable. They leave able to brief senior management on material control in terms that support a decision. Work concludes with a self-assessment of this part of health and pharmaceutical services that participants can repeat annually.
Expected Learning Outcomes
Sequence improvements to material control so that each step makes the next one easier.
Design a practical operating method for pharmaceutical raw material control that fits the organisation's size and maturity.
Design escalation for clinical deterioration detected through material control.
Build informed consent and ethics practice into pharmaceutical raw material control.
Identify the failure points in material control most likely to cause loss, and control them first.
Design medication and treatment safety controls within pharmaceutical raw material control.
Who Should Attend
Health information and records staff supporting pharmaceutical raw material control.
Quality and patient safety officers monitoring material control.
Procurement and contracting staff whose agreements set obligations around pharmaceutical raw material control.
Supply chain and biomedical staff supporting material control.
Business partners who must understand pharmaceutical raw material control well enough to challenge it.
Accreditation and compliance officers preparing evidence on material control.
Course Modules
Pharmaceutical raw material control: incident reporting, investigation and learning
2 sessions · 8 pointsSession 1Investigating an adverse event involving pharmaceutical raw material control
- Check that consent processes within pharmaceutical raw material control are genuinely informed.
- Record the rationale for each significant choice made about material control.
- Confirm licensing and regulatory requirements applying to pharmaceutical raw material control are met.
- Apply structured root cause analysis to the last adverse event involving material control.
Session 2The evidence assessors will ask for on material control
- Arrange the handover of pharmaceutical raw material control so capability survives staff changes.
- Match staffing levels on material control to measured demand across the week.
- Close the loop: confirm changes to pharmaceutical raw material control improved the indicator they targeted.
- Plan continuity of material control during surge and outbreak conditions.
Material control: quality indicators and patient outcome
2 sessions · 8 pointsSession 1Medication safety checkpoints inside material control
- Identify the data already collected that bears on pharmaceutical raw material control.
- Map the handovers in material control between functions and secure them.
- Rank the weaknesses in pharmaceutical raw material control by consequence rather than by ease of fixing.
- Define the trigger that would require material control to be redesigned.
Session 2Auditing material control at the bedside, not in the binder
- Confirm that reporting on pharmaceutical raw material control reaches the people who can act.
- Cost material control per episode and identify avoidable waste.
- Prepare the summary of pharmaceutical raw material control that senior management will read.
- Confirm competence and continuing development for staff delivering material control.
Material control: supply, cold chain and availability
2 sessions · 8 pointsSession 1What patients actually experience during material control
- Set escalation thresholds for pharmaceutical raw material control that work out of hours.
- Verify six months later that changes to material control have held.
- Reduce unwarranted variation in pharmaceutical raw material control between shifts and sites.
- Identify single points of dependency in material control and reduce them.
Session 2The hard cases in pharmaceutical raw material control and how to reason about them
- Verify cold chain and storage conditions for materials used in pharmaceutical raw material control.
- Define escalation criteria for deterioration detected through material control.
- Review whether pharmaceutical raw material control is aligned with the objectives of the clinical service.
- Select quality indicators for material control that measure outcome rather than activity.
Material control: regulation, licensing and accreditation evidence
2 sessions · 8 pointsSession 1Making material control work when resources are constrained
- Check that pharmaceutical raw material control still works when volumes rise unexpectedly.
- Rehearse the briefing on material control that would follow an incident.
- Confirm patient data handled within pharmaceutical raw material control meets confidentiality obligations.
- Identify infection transmission risks created by material control and control them.
Session 2Building the method for material control step by step
- Audit pharmaceutical raw material control by observing practice, not by reading policy.
- Confirm that contractual obligations around material control are understood.
- Remove steps in pharmaceutical raw material control that add effort without adding assurance.
- Build medication safety checks into material control at the point of highest risk.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.